GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Gross Margin %

Perseus Proteomics (TSE:4882) Gross Margin % : 94.52% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Perseus Proteomics's Gross Profit for the three months ended in Dec. 2023 was 円19.61 Mil. Perseus Proteomics's Revenue for the three months ended in Dec. 2023 was 円20.75 Mil. Therefore, Perseus Proteomics's Gross Margin % for the quarter that ended in Dec. 2023 was 94.52%.


The historical rank and industry rank for Perseus Proteomics's Gross Margin % or its related term are showing as below:

TSE:4882' s Gross Margin % Range Over the Past 10 Years
Min: 29.74   Med: 92.82   Max: 94.34
Current: 89.01


During the past 6 years, the highest Gross Margin % of Perseus Proteomics was 94.34%. The lowest was 29.74%. And the median was 92.82%.

TSE:4882's Gross Margin % is ranked better than
97.16% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.405 vs TSE:4882: 89.01

Perseus Proteomics had a gross margin of 94.52% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Perseus Proteomics was 17.70% per year.


Perseus Proteomics Gross Margin % Historical Data

The historical data trend for Perseus Proteomics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Gross Margin % Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial 93.09 92.55 94.34 94.18 91.86

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.21 82.82 93.83 85.89 94.52

Competitive Comparison of Perseus Proteomics's Gross Margin %

For the Drug Manufacturers - General subindustry, Perseus Proteomics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perseus Proteomics's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's Gross Margin % falls into.



Perseus Proteomics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Perseus Proteomics's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=86.5 / 94.201
=(Revenue - Cost of Goods Sold) / Revenue
=(94.201 - 7.669) / 94.201
=91.86 %

Perseus Proteomics's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=19.6 / 20.748
=(Revenue - Cost of Goods Sold) / Revenue
=(20.748 - 1.136) / 20.748
=94.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Perseus Proteomics  (TSE:4882) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Perseus Proteomics had a gross margin of 94.52% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Perseus Proteomics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Perseus Proteomics (TSE:4882) Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines